Mucins are valuable biomarkers in the diagnosis of various diseases. Changes in the expression and glycosylation patterns of mucins can indicate pathological conditions. For example, overexpression of MUC1 is commonly observed in breast cancer, making it a target for diagnostic and therapeutic interventions.
